Literature DB >> 31912158

SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.

Pooja Panwalkar1, Drew Pratt1, Chan Chung1, Derek Dang1, Paul Le2, Daniel Martinez2, Jill M Bayliss1, Kyle S Smith3, Mike Adam4, Steven Potter4, Paul A Northcott3, Leo Mascarenhas5,6, Jared Shows7, Bruce Pawel8, Ashley Margol5,6, Annie Huang9, Alexander R Judkins8, Sriram Venneti1,10.   

Abstract

BACKGROUND: Rhabdoid tumors (RTs) arise within (atypical teratoid/rhabdoid tumor [AT/RT]) or outside the brain (extra [e]CNS-RT) and are driven mainly by inactivation of the SWItch/sucrose nonfermentable (SWI/SNF) complex subunit SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1). A pathognomonic hallmark of RTs is heterogeneous multilineage differentiation, including anomalous neuronal differentiation in some eCNS-RTs. Because remodeling of the SWI/SNF complex regulates differentiation, we hypothesized that SWI/SNF Brahma-associated factors (BAF) and polybromo-associated BAF (PBAF) complex heterogeneity are related to both multilineage differentiation and clinical outcome.
METHODS: We performed an integrated analysis of SWI/SNF complex alterations in the developing kidney and cerebellum (most common regions of RT origin) in comparison to eCNS-RT (n = 14) and AT/RT (n = 25) tumors. RT samples were interrogated using immunohistochemistry, DNA methylation, and gene expression analyses.
RESULTS: The SWI/SNF BAF paralogs actin-like protein (ACTL)6A and ACTL6B were expressed in a mutually exclusive manner in the developing cerebellum and kidney. In contrast, a subset of eCNS-RTs lost mutual exclusivity and coexpressed both subunits. These tumors showed aberrant DNA methylation of genes that regulate neuronal and renal development and demonstrated immunohistochemical evidence of neuronal differentiation. In addition, low expression of the PBAF subunit polybromo-1 (PBRM1) identified a group of AT/RTs in younger children with better overall prognosis. PBRM1-low AT/RT and eCNS-RTs showed altered DNA methylation and gene expression in immune-related genes. PBRM1 knockdown resulted in lowering immunosuppressive cytokines, and PBRM1 levels in tumor samples showed an inverse relationship with cluster of differentiation (CD)8 cytotoxic T-cell infiltration.
CONCLUSIONS: Heterogeneity in SWI/SNF BAF (ACTL6A/ACTL6B) and PBAF (PBRM1) subunits is related to histogenesis, contributes to the immune microenvironment and prognosis in RTs, and may inform opportunities to develop immunotherapies.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AT/RT; SWI/SNF complex; differentiation; immune infiltration; rhabdoid tumor

Mesh:

Substances:

Year:  2020        PMID: 31912158      PMCID: PMC7283032          DOI: 10.1093/neuonc/noaa004

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  27 in total

1.  A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.

Authors:  Deng Pan; Aya Kobayashi; Peng Jiang; Lucas Ferrari de Andrade; Rong En Tay; Adrienne M Luoma; Daphne Tsoucas; Xintao Qiu; Klothilda Lim; Prakash Rao; Henry W Long; Guo-Cheng Yuan; John Doench; Myles Brown; X Shirley Liu; Kai W Wucherpfennig
Journal:  Science       Date:  2018-01-04       Impact factor: 47.728

2.  Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.

Authors:  Amaury Leruste; Jimena Tosello; Rodrigo Nalio Ramos; Arnault Tauziède-Espariat; Solène Brohard; Zhi-Yan Han; Kevin Beccaria; Mamy Andrianteranagna; Pamela Caudana; Jovan Nikolic; Céline Chauvin; Leticia Laura Niborski; Valeria Manriquez; Wilfrid Richer; Julien Masliah-Planchon; Sandrine Grossetête-Lalami; Mylene Bohec; Sonia Lameiras; Sylvain Baulande; Celio Pouponnot; Aurore Coulomb; Louise Galmiche; Didier Surdez; Nicolas Servant; Julie Helft; Christine Sedlik; Stéphanie Puget; Philippe Benaroch; Olivier Delattre; Joshua J Waterfall; Eliane Piaggio; Franck Bourdeaut
Journal:  Cancer Cell       Date:  2019-11-07       Impact factor: 31.743

3.  p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.

Authors:  Sriram Venneti; Paul Le; Daniel Martinez; Katherine W Eaton; Nikhil Shyam; Kelly L Jordan-Sciutto; Bruce Pawel; Jaclyn A Biegel; Alexander R Judkins
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

4.  Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.

Authors:  Sriram Venneti; Paul Le; Daniel Martinez; Sharon X Xie; Lisa M Sullivan; Lucy B Rorke-Adams; Bruce Pawel; Alexander R Judkins
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

5.  Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.

Authors:  Pascal D Johann; Susanne Bens; Florian Oyen; Rabea Wagener; Caterina Giannini; Arie Perry; Jack M Raisanen; Gerald F Reis; Sumihito Nobusawa; Kazunori Arita; Jörg Felsberg; Guido Reifenberger; Abbas Agaimy; Rolf Buslei; David Capper; Stefan M Pfister; Reinhard Schneppenheim; Reiner Siebert; Michael C Frühwald; Werner Paulus; Marcel Kool; Martin Hasselblatt
Journal:  Am J Surg Pathol       Date:  2018-04       Impact factor: 6.394

Review 6.  ATP-dependent chromatin remodeling in neural development.

Authors:  Andrew S Yoo; Gerald R Crabtree
Journal:  Curr Opin Neurobiol       Date:  2009-05-11       Impact factor: 6.627

7.  Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation.

Authors:  Serap Erkek; Pascal D Johann; Martina A Finetti; Yiannis Drosos; Hsien-Chao Chou; Marc Zapatka; Dominik Sturm; David T W Jones; Andrey Korshunov; Marina Rhyzova; Stephan Wolf; Jan-Philipp Mallm; Katja Beck; Olaf Witt; Andreas E Kulozik; Michael C Frühwald; Paul A Northcott; Jan O Korbel; Peter Lichter; Roland Eils; Amar Gajjar; Charles W M Roberts; Daniel Williamson; Martin Hasselblatt; Lukas Chavez; Stefan M Pfister; Marcel Kool
Journal:  Cancer Cell       Date:  2018-12-27       Impact factor: 31.743

8.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

9.  Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration.

Authors:  Hye-Jung E Chun; Pascal D Johann; Katy Milne; Marc Zapatka; Annette Buellesbach; Naveed Ishaque; Murat Iskar; Serap Erkek; Lisa Wei; Basile Tessier-Cloutier; Jake Lever; Emma Titmuss; James T Topham; Reanne Bowlby; Eric Chuah; Karen L Mungall; Yussanne Ma; Andrew J Mungall; Richard A Moore; Michael D Taylor; Daniela S Gerhard; Steven J M Jones; Andrey Korshunov; Manfred Gessler; Kornelius Kerl; Martin Hasselblatt; Michael C Frühwald; Elizabeth J Perlman; Brad H Nelson; Stefan M Pfister; Marco A Marra; Marcel Kool
Journal:  Cell Rep       Date:  2019-11-07       Impact factor: 9.423

10.  Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.

Authors:  Jonathon Torchia; Brian Golbourn; Shengrui Feng; King Ching Ho; Patrick Sin-Chan; Alexandre Vasiljevic; Joseph D Norman; Paul Guilhamon; Livia Garzia; Natalia R Agamez; Mei Lu; Tiffany S Chan; Daniel Picard; Pasqualino de Antonellis; Dong-Anh Khuong-Quang; Aline C Planello; Constanze Zeller; Dalia Barsyte-Lovejoy; Lucie Lafay-Cousin; Louis Letourneau; Mathieu Bourgey; Man Yu; Deena M A Gendoo; Misko Dzamba; Mark Barszczyk; Tiago Medina; Alexandra N Riemenschneider; A Sorana Morrissy; Young-Shin Ra; Vijay Ramaswamy; Marc Remke; Christopher P Dunham; Stephen Yip; Ho-Keung Ng; Jian-Qiang Lu; Vivek Mehta; Steffen Albrecht; Jose Pimentel; Jennifer A Chan; Gino R Somers; Claudia C Faria; Lucia Roque; Maryam Fouladi; Lindsey M Hoffman; Andrew S Moore; Yin Wang; Seung Ah Choi; Jordan R Hansford; Daniel Catchpoole; Diane K Birks; Nicholas K Foreman; Doug Strother; Almos Klekner; Laszló Bognár; Miklós Garami; Péter Hauser; Tibor Hortobágyi; Beverly Wilson; Juliette Hukin; Anne-Sophie Carret; Timothy E Van Meter; Eugene I Hwang; Amar Gajjar; Shih-Hwa Chiou; Hideo Nakamura; Helen Toledano; Iris Fried; Daniel Fults; Takafumi Wataya; Chris Fryer; David D Eisenstat; Katrin Scheinemann; Adam J Fleming; Donna L Johnston; Jean Michaud; Shayna Zelcer; Robert Hammond; Samina Afzal; David A Ramsay; Nongnuch Sirachainan; Suradej Hongeng; Noppadol Larbcharoensub; Richard G Grundy; Rishi R Lulla; Jason R Fangusaro; Harriet Druker; Ute Bartels; Ronald Grant; David Malkin; C Jane McGlade; Theodore Nicolaides; Tarik Tihan; Joanna Phillips; Jacek Majewski; Alexandre Montpetit; Guillaume Bourque; Gary D Bader; Alyssa T Reddy; G Yancey Gillespie; Monika Warmuth-Metz; Stefan Rutkowski; Uri Tabori; Mathieu Lupien; Michael Brudno; Ulrich Schüller; Torsten Pietsch; Alexander R Judkins; Cynthia E Hawkins; Eric Bouffet; Seung-Ki Kim; Peter B Dirks; Michael D Taylor; Anat Erdreich-Epstein; Cheryl H Arrowsmith; Daniel D De Carvalho; James T Rutka; Nada Jabado; Annie Huang
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 31.743

View more
  7 in total

1.  SWI/SNF complex differences promote cellular heterogeneity in rhabdoid tumors.

Authors:  Charles G Eberhart; Jeffrey A Rubens
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

Review 2.  Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors.

Authors:  Chang Zhang; Hao Li
Journal:  Pediatr Investig       Date:  2022-05-23

3.  ACTL6A Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells and Correlates with Poor Clinical Outcomes.

Authors:  Rui-Zhe Li; Yun-Yun Li; Hui Qin; Shan-Shan Li
Journal:  Onco Targets Ther       Date:  2021-01-13       Impact factor: 4.147

4.  Upregulated Expression of Actin-Like 6A is a Risk Factor Affecting the Prognosis of Pancreatic Cancer.

Authors:  Zhong Zhang; Haochun Guo; Haijun Zhang
Journal:  Cancer Manag Res       Date:  2021-12-30       Impact factor: 3.989

Review 5.  Rare Hereditary Gynecological Cancer Syndromes.

Authors:  Takafumi Watanabe; Shu Soeda; Yuta Endo; Chikako Okabe; Tetsu Sato; Norihito Kamo; Makiko Ueda; Manabu Kojima; Shigenori Furukawa; Hidekazu Nishigori; Toshifumi Takahashi; Keiya Fujimori
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

6.  Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.

Authors:  Zhiyi Zhou; Dandan Huang; Shudong Yang; Jiabei Liang; Xuan Wang; Qiu Rao
Journal:  Pathol Oncol Res       Date:  2022-07-19       Impact factor: 2.874

7.  Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup.

Authors:  Francesca Zin; Jennifer A Cotter; Christine Haberler; Matthias Dottermusch; Julia Neumann; Ulrich Schüller; Leonille Schweizer; Christian Thomas; Karolina Nemes; Pascal D Johann; Marcel Kool; Michael C Frühwald; Werner Paulus; Alexander Judkins; Martin Hasselblatt
Journal:  Brain Pathol       Date:  2021-05-03       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.